He founded Logical Information Machines (LIM) in 1988 with three other partners, each putting up $1,000 in capital for a total $4,000 in capital and, under his direction as President, turned the company into a business with revenues over $20 million per year. At LIM, Mr. Kolton created a proprietary time-series database technology called “Historis”; and a desktop application called the “Market Information Machine” (“MIM”) that helps clients make sense of the mountains of information contained in the data base. LIM evolved from a software company to become a leading provider of data and analytics for some of the world’s largest asset managers, banks, oil companies, power and natural gas trading firms, utilities, and agriculture and commodities trading firms. The company collects, unifies, and conducts quality assurance on data from more than 180 providers in the energy, financial, and agriculture sectors and provides clients with one central source for data intelligence and analysis. Clients also had the flexibility to use LIM’s tools for analyzing their own proprietary data, which they may have been collecting for years. Traders and risk managers relied on LIM as their information hub. The Company employed people in Austin, Houston, Chicago, New York, and London.

    LIM was sold to Morningstar in 2009 for over $50 million and Mr. Kolton went out searching for the next big thing.

After the sale of LIM, Tony Kolton invented The Earnings Information Machine (EIM), a research tool that helps traders predict if a company will beat or miss on their earnings report, as well as the TychoNova platform and T-Score. TychoNova incorporates Mr. Kolton’s years of research and trading knowledge to analyze and predict price movements of futures, commodities, crypto and equities with a high degree of accuracy. Mr. Kolton remains a highly sought-after consultant on the markets with clients including several multi-billion dollar hedge funds, high net worth family offices and investors on a global basis.

He is also the Chief Executive Officer, Chairman and Founder of Regenerative Medical Solutions (RMS), a company utilizing induced pluripotent (non embryonic) stem cells to target a cure for diabetes.